All Stories

  1. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
  2. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
  3. Identifying Epstein–Barr virus peptide sequences associated with differential IgG antibody response
  4. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses
  5. HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
  6. A prenylated dsRNA sensor protects against severe COVID-19
  7. Development of an Electrochemical CCL17/TARC Biosensor toward Rapid Triage and Monitoring of Classic Hodgkin Lymphoma
  8. Detection of SARS‐CoV‐2 in respiratory samples from cats in the UK associated with human‐to‐cat transmission
  9. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
  10. Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study
  11. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
  12. The prevalence and characterisation of TRAF3 and POT1 mutations in canine B-cell lymphoma
  13. Send cat and dog samples to test for SARS‐CoV‐2
  14. Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study
  15. Primary Epstein-Barr virus infection with and without infectious mononucleosis
  16. Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma
  17. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
  18. Inherited Chromosomally Integrated Human Herpesvirus 6 Genomes Are Ancient, Intact, and Potentially Able To Reactivate from Telomeres
  19. Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies
  20. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts
  21. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis
  22. HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q
  23. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma
  24. Human leukocyte antigens and genetic susceptibility to lymphoma
  25. Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas
  26. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis
  27. The Role of Viruses in the Genesis of Hodgkin Lymphoma
  28. Germ-Line Transmitted, Chromosomally Integrated HHV-6 and Classical Hodgkin Lymphoma
  29. A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
  30. Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin’s lymphoma
  31. Molecular Methods of Virus Detection in Lymphoma
  32. Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
  33. Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups
  34. The Retrovirus XMRV Is not Directly Involved in the Pathogenesis of Common Types of Lymphoid Malignancy
  35. The molecular pathogenesis of Hodgkin lymphoma
  36. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
  37. Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine
  38. The Role of Viruses in the Genesis of Hodgkin Lymphoma
  39. SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies
  40. Mannose-Binding Lectin Genotypes and Susceptibility to Epstein-Barr Virus Infection in Infancy
  41. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
  42. Mutations of NFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non‐EBV‐associated cases
  43. Expression and function of T cell homing molecules in Hodgkin’s lymphoma
  44. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
  45. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma
  46. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection
  47. The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease
  48. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland
  49. Measles virus and classical Hodgkin lymphoma: No evidence for a direct association
  50. The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes
  51. Author's reply
  52. Viruses and Hodgkin lymphoma: No evidence of polyomavirus genomes in tumor biopsies
  53. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study
  54. Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma
  55. Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma
  56. Viruses and lymphoma/leukaemia
  57. Germline mutations and polymorphisms in theNFKBIA gene in Hodgkin lymphoma
  58. Epstein-Barr virus-related nasal and cutaneous T-cell lymphoma in an immunosuppressed patient
  59. Interdigitating dendritic cell sarcoma of salivary gland associated lymphoid tissue not associated with HHV-8 or EBV infection
  60. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates
  61. Risk Factors for Hodgkin's Lymphoma by EBV Status and Significance of Detection of EBV Genomes in Serum of Patients with EBV-Associated Hodgkin's Lymphoma
  62. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults
  63. Classical Hodgkin lymphoma is associated with frequent gains of 17q
  64. Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom
  65. Hodgkin lymphoma and Epstein-Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated
  66. Viruses and Hodgkin disease: No evidence of novel herpesviruses in non-EBV-associated lesions
  67. Hodgkin's disease in the elderly: current status and future directions
  68. Viruses and Hodgkin's lymphoma
  69. Primary T cell lymphoma of salivary gland: a report of a case and review of the literature
  71. HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits
  72. Screening for herpesvirus genomes in common acute lymphoblastic leukemia
  73. B-lymphotropic viruses in a novel tropical splenic lymphoma
  74. Risk factors for Hodgkin’s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents
  75. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia
  76. Analysis of Epstein–Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom
  77. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease
  78. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
  79. Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy
  80. Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis
  81. Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease
  82. A New Human Retrovirus: A Role in Lymphoma?
  83. HHV-8 and multiple myeloma in the UK
  84. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein
  85. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
  86. 1 The epidemiology of Hodgkin's disease
  87. “Cytomegalovirus disease” in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?
  88. Epidemiology of EBV and Hodgkin's lymphoma
  89. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: Results of a case-control study
  90. A Model to Study Viral and Cytokine Involvement in Sjogren's Syndrome
  91. Prognostic significance of Epstein-Barr virus association in Hodgkin's disease
  92. Prevalence of Antibody to Human Herpesvirus 7 by Age
  93. Hodgkin's disease and Epstein-Barr virus
  94. Chapter 17 Detection of HHV-6 using polymerase chain reaction amplification
  95. Chapter 2 The epidemiology of human herpesvirus-6
  96. Viral involvement in hodgkin's disease
  97. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.
  98. Letters to the editor
  99. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples
  100. Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease
  101. Detection of human herpesvirus-6 DNA in peripheral blood and saliva
  102. Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma
  103. The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma
  105. Sensitive ELISA for the gp120 and gp160 Surface Glycoproteins of HIV-1
  106. Pathogenesis of retroviral infections
  108. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
  109. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
  110. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA
  111. Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells
  112. Nucleotide sequence of transforming human c-siscDNA clones with homology to platelet-derived growth factor
  113. Uterine perforation by a Copper 7 intrauterine contraceptive device with subsequent penetration of the appendix.